These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31714191)

  • 1. Pharmacokinetics of Ferumoxytol in the Abdomen and Pelvis: A Dosing Study with 1.5- and 3.0-T MRI Relaxometry.
    Wells SA; Schubert T; Motosugi U; Sharma SD; Campo CA; Kinner S; Woo KM; Hernando D; Reeder SB
    Radiology; 2020 Jan; 294(1):108-116. PubMed ID: 31714191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
    Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
    Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxivity of Ferumoxytol at 1.5 T and 3.0 T.
    Knobloch G; Colgan T; Wiens CN; Wang X; Schubert T; Hernando D; Sharma SD; Reeder SB
    Invest Radiol; 2018 May; 53(5):257-263. PubMed ID: 29215401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Bowman AW; Gooch CR; Alexander LF; Desai MA; Bolan CW
    Abdom Radiol (NY); 2021 May; 46(5):2203-2218. PubMed ID: 33090256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.
    Iv M; Samghabadi P; Holdsworth S; Gentles A; Rezaii P; Harsh G; Li G; Thomas R; Moseley M; Daldrup-Link HE; Vogel H; Wintermark M; Cheshier S; Yeom KW
    Radiology; 2019 Jan; 290(1):198-206. PubMed ID: 30398435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains.
    Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE
    Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults.
    Storey P; Lim RP; Chandarana H; Rosenkrantz AB; Kim D; Stoffel DR; Lee VS
    Invest Radiol; 2012 Dec; 47(12):717-24. PubMed ID: 23070094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
    Nguyen KL; Yoshida T; Kathuria-Prakash N; Zaki IH; Varallyay CG; Semple SI; Saouaf R; Rigsby CK; Stoumpos S; Whitehead KK; Griffin LM; Saloner D; Hope MD; Prince MR; Fogel MA; Schiebler ML; Roditi GH; Radjenovic A; Newby DE; Neuwelt EA; Bashir MR; Hu P; Finn JP
    Radiology; 2019 Dec; 293(3):554-564. PubMed ID: 31638489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
    Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
    Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative ferumoxytol-enhanced MRI in pregnancy: A feasibility study in the nonhuman primate.
    Zhu A; Reeder SB; Johnson KM; Nguyen SM; Fain SB; Bird IM; Golos TG; Wieben O; Shah DM; Hernando D
    Magn Reson Imaging; 2020 Jan; 65():100-108. PubMed ID: 31655139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasmall superparamagnetic iron oxide nanoparticle uptake as noninvasive marker of aortic wall inflammation on MRI: proof of concept study.
    Hedgire S; Krebill C; Wojtkiewicz GR; Oliveira I; Ghoshhajra BB; Hoffmann U; Harisinghani MG
    Br J Radiol; 2018 Dec; 91(1092):20180461. PubMed ID: 30160173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.
    Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG
    AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography.
    Stabi KL; Bendz LM
    Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
    Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
    J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of R2* and R2 magnetic resonance imaging relaxation rate measurements in murine liver after a single administration of 3 different iron oxide-based contrast agents.
    Kalber TL; Smith CJ; Howe FA; Griffiths JR; Ryan AJ; Waterton JC; Robinson SP
    Invest Radiol; 2005 Dec; 40(12):784-91. PubMed ID: 16304482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxymethyldextran-A2-Gd-DOTA enhancement patterns in the abdomen and pelvis in an animal model.
    Daldrup-Link HE; Link TM; Möller HE; Wiedermann D; Bonnemain B; Corot C; Rummeny EJ
    Eur Radiol; 2001; 11(7):1276-84. PubMed ID: 11471624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of cerebral blood volume using quantitative susceptibility mapping, R
    Rivera-Rivera LA; Schubert T; Johnson KM
    NMR Biomed; 2019 Dec; 32(12):e4175. PubMed ID: 31482602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects.
    Storey P; Arbini AA
    J Magn Reson Imaging; 2014 Jun; 39(6):1401-10. PubMed ID: 24123697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of microvascular cerebral blood volume changes over the cardiac cycle with ferumoxytol-enhanced T
    Rivera-Rivera LA; Johnson KM; Turski PA; Wieben O; Schubert T
    Magn Reson Med; 2019 Jun; 81(6):3588-3598. PubMed ID: 30756424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.